Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of a structural lipid emulsion, amino acids, and glucose refers to a specialized parenteral nutrition (PN) system, most notably marketed under the brand name **StructoKabiven**. This product is typically supplied in a three-chamber bag (3CB) to maintain the stability of the individual components until administration. The defining feature is the 'structural lipid' (Structolipid), which consists of structured triglycerides (STG) where medium-chain fatty acids (MCFA) and long-chain fatty acids (LCFA) are randomly esterified on the same glycerol backbone. This design optimizes metabolic clearance; MCFAs provide a rapid energy source, while LCFAs provide essential fatty acids, and the structured format ensures more efficient hydrolysis by lipoprotein lipase compared to physical mixtures of MCT and LCT. The amino acid component provides nitrogen for protein synthesis, and glucose serves as the primary carbohydrate energy source. It is indicated for adult patients requiring parenteral nutrition in states of malnutrition or postoperative recovery when oral or enteral intake is inadequate or impossible.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on amino acids + glucose + structured triglycerides.